Publikation
Accelerating Innovations for Enhanced Brain Health. Can Artificial Intelligence Advance New Pathways for Drug Discovery for Alzheimer’s and other Neurodegenerative Disorders?
A. S. Khachaturian; Andreas Dengel; V. Dočkal; P. Hroboň; M. Tolar
In: The Journal of Prevention of Alzheimer's Disease (JPAD), Vol. 10, No. 1, Pages 1-4, Editorial initiative of the Clinical Trials on Alzheimer's Desease Conference, 1/2023.
Zusammenfassung
Artificial intelligence/machine learning (AI/ML) offers new solutions to untangle the complexity involved in discovery of new intervention targets for neurodegenerative disorders